INBX
INHIBRX BIOSCIENCES INC
CUSIP: 45720N103
INHIBRX BIOSCIENCES INC (INBX) — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.
About
InhibRx Biosciences is a clinical-stage biotechnology company focused on the discovery and development of novel biologic therapeutics. The company leverages its proprietary platforms to create antibody-based treatments aimed at addressing serious diseases with significant unmet medical needs. InhibRx primarily targets indications within the areas of immuno-oncology, rare diseases, and other specialty conditions.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
AI Agent
Try asking...